loadpatents
name:-0.031721830368042
name:-0.017355918884277
name:-0.0061631202697754
RAFII; Shahin Patent Filings

RAFII; Shahin

Patent Applications and Registrations

Patent applications and USPTO patent grants for RAFII; Shahin.The latest application filed is for "methods for organ regeneration".

Company Profile
7.22.27
  • RAFII; Shahin - New York NY
  • RAFII; Shahin - Ithaca NY
  • Rafii; Shahin - Great Neck NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Organ Regeneration
App 20210236598 - RAFII; Shahin ;   et al.
2021-08-05
Methods And Compositions For Promoting Survival And Proliferation Of Endothelial Cells And Stimulating Angiogensis
App 20210155899 - RAFII; Shahin ;   et al.
2021-05-27
Methods for organ regeneration
Grant 10,946,066 - Rafii , et al. March 16, 2
2021-03-16
Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
Grant 10,865,379 - Rafii , et al. December 15, 2
2020-12-15
Stable Three-dimensional Blood Vessels And Methods For Forming The Same
App 20190376044 - RAFII; Shahin ;   et al.
2019-12-12
Engineering Blood Vessel Cells For Transplantation
App 20190352601 - RAFII; Shahin ;   et al.
2019-11-21
Methods And Compositions For Promoting Survival And Proliferation Of Endothelial Cells And Stimulating Angiogensis
App 20180258386 - RAFII; Shahin ;   et al.
2018-09-13
Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
Grant 9,944,897 - Rafii , et al. April 17, 2
2018-04-17
Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer
Grant 9,927,444 - Vahdat , et al. March 27, 2
2018-03-27
Generation of functional and durable endothelial cells from human amniotic fluid-derived cells
Grant 9,637,723 - Rafii , et al. May 2, 2
2017-05-02
Inhibition of angiogenesis
Grant 9,179,654 - Lagos-Quintana , et al. November 10, 2
2015-11-10
Generation Of Functional And Durable Endothelial Cells From Human Amniotic Fluid-derived Cells
App 20150147299 - Rafii; Shahin ;   et al.
2015-05-28
Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands
Grant 8,853,163 - Hempstead , et al. October 7, 2
2014-10-07
Bone Marrow-derived Hematopoietic Progenitor Cells And Endothelial Progenitor Cells As Prognostic Indicators For Cancer
App 20140134190 - Vahdat; Linda ;   et al.
2014-05-15
Methods And Compositions For Promoting Survival And Proliferation Of Endothelial Cells And Stimulating Angiogenesis
App 20140045260 - RAFII; Shahin ;   et al.
2014-02-13
Methods For Organ Regeneration
App 20130224161 - Rafii; Shahin ;   et al.
2013-08-29
Endothelial cells expressing adenovirus E4ORF1 and methods of use thereof
Grant 8,465,732 - Rafii , et al. June 18, 2
2013-06-18
Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
Grant 8,465,738 - Lyden , et al. June 18, 2
2013-06-18
Slitrks as markers for stem and progenitor cells and methods of use thereof
Grant 8,043,803 - Rafii , et al. October 25, 2
2011-10-25
Gpr125 As A Marker For Stem And Progenitor Cells And Methods Use Thereof
App 20100330043 - Rafii; Shahin ;   et al.
2010-12-30
Methods For Regulating Angiogenesis And Vascular Integrity Using Trk Receptor Ligands
App 20100227823 - HEMPSTEAD; Barbara L. ;   et al.
2010-09-09
Use Of Vascular Endothelial Growth Factor Receptor 1+ Cells In Treating And Monitoring Cancer And In Screening For Chemotherapeutics
App 20100150932 - Lyden; David ;   et al.
2010-06-17
Methods for increasing capillary density and maintaining viability of microvascular cardiac endothelial cells using trk receptor ligands
Grant 7,723,293 - Hempstead , et al. May 25, 2
2010-05-25
Methods for Treating Hematopoietic Neoplasms
App 20090264382 - CHAPLIN; David ;   et al.
2009-10-22
Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
Grant 7,598,043 - Lyden , et al. October 6, 2
2009-10-06
Platelet-derived growth factor protection of cardiac myocardium
Grant 7,514,261 - Edelberg , et al. April 7, 2
2009-04-07
Slitrks As Markers For Stem And Progenitor Cells And Methods Of Use Thereof
App 20080267922 - Rafii; Shahin ;   et al.
2008-10-30
Stem cell-specific promoters and their use
Grant 7,396,680 - Shmelkov , et al. July 8, 2
2008-07-08
Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
App 20070110735 - Hempstead; Barbara L. ;   et al.
2007-05-17
Endothelial precursor cells for enhancing and restoring vascular function
Grant 7,135,171 - Edelberg , et al. November 14, 2
2006-11-14
Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
App 20060134080 - Lyden; David ;   et al.
2006-06-22
Purified populations of stem cells
App 20050142659 - Rafii, Shahin ;   et al.
2005-06-30
Stem cell-specific promoters and their use
App 20050125849 - Shmelkov, Sergey V. ;   et al.
2005-06-09
Purified populations of stem cells
Grant 6,852,533 - Rafii , et al. February 8, 2
2005-02-08
Isolation and mobilization of stem cells expressing vegfr-1
App 20050026220 - Rafii, Shahin ;   et al.
2005-02-03
Vegfr-1 antibodies to treat breast cancer
App 20040241160 - Wu, Yan ;   et al.
2004-12-02
Adult stem cell recruitment
App 20040071687 - Rafii, Shahin ;   et al.
2004-04-15
Endothelial precursor cells for enhancing and restoring vascular function
App 20040001807 - Edelberg, Jay ;   et al.
2004-01-01
Platelet-derived growth factor protection of cardiac myocardium
App 20030091547 - Edelberg, Jay M. ;   et al.
2003-05-15
Purified Populations Of Endothelial Progenitor Cells
App 20020051762 - RAFII, SHAHIN ;   et al.
2002-05-02
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed